Literature DB >> 9541319

Endovascular therapy of idiopathic cavernous aneurysms over 11 years.

G Bavinzski1, M Killer, H Ferraz-Leite, A Gruber, C E Gross, B Richling.   

Abstract

PURPOSE: We report our experience with 42 patients with 48 cavernous carotid aneurysms, of whom 32 were treated with endovascular techniques and 10 were managed conservatively.
METHODS: The 48 aneurysms were divided into two subgroups by location: 23 were at the C-3 portion of the carotid artery (small, saccular aneurysms with an epidural, partly intracavernous location) and 25 originated at the C4-5 segment (large or giant often fusiform aneurysms with a true intracavernous location). Morphologic features in both groups correlated well with differences in clinical presentation and also influenced therapy. Sixteen of the 25 C4-5 aneurysms (all large or giant) were treated by balloon occlusion of the parent artery, four (with narrow necks) were treated with Guglielmi detachable coils (GDCs), and five were not treated (asymptomatic or minimally symptomatic). Twelve of 13 C-3 aneurysms were treated with GDCs. Ten C-3 aneurysms were not treated.
RESULTS: Ophthalmoplegia resolved or improved in nine of 12 patients treated with parent artery occlusion. All aneurysms treated by carotid occlusion thrombosed. Twelve of the 17 aneurysms treated with GDCs were 100% filled by the coils, four were 80% to 95% filled, and one was only 40% filled. Seven of the 100% filled aneurysms remained completely occluded, two showed slight coil compaction, and in three, follow-up angiography was not available. Among the incompletely filled aneurysms, two remained unchanged, one showed progressive thrombosis, a fourth revealed coil compaction, and in one, follow-up angiography was not available. One thromboembolic stroke and three transient ischemic attacks occurred perioperatively, for a permanent morbidity of 3.5% and a transient morbidity of 9%. There was no mortality. Mean clinical follow-up was 33 months; mean angiographic follow-up of patients treated with GDCs was 11 months.
CONCLUSION: Surgically difficult cavernous aneurysms can be obliterated by embolization with excellent clinical results. Detachable coils have become an important endovascular tool, especially for narrow-necked cavernous aneurysms of the C-3 segment, which can be protected against rupture in the subarachnoid space in most cases.

Entities:  

Mesh:

Year:  1998        PMID: 9541319      PMCID: PMC8338241     

Source DB:  PubMed          Journal:  AJNR Am J Neuroradiol        ISSN: 0195-6108            Impact factor:   3.825


  13 in total

1.  Superior hypophyseal artery aneurysms have the lowest recurrence rate with endovascular therapy.

Authors:  N Chalouhi; S Tjoumakaris; A S Dumont; L F Gonzalez; C Randazzo; D Gordon; R Chitale; R Rosenwasser; P Jabbour
Journal:  AJNR Am J Neuroradiol       Date:  2012-03-08       Impact factor: 3.825

2.  Management of a direct carotid cavernous fistula caused by rupture of a cavernous aneurysm previously embolized with coils.

Authors:  W L Poon; H Alvarez; P Lasjaunias
Journal:  Interv Neuroradiol       Date:  2004-10-22       Impact factor: 1.610

3.  Comparison of technetium Tc 99m hexamethylpropyleneamine oxime single-photon emission tomograph with stump pressure during the balloon occlusion test of the internal carotid artery.

Authors:  Noriaki Tomura; Koichi Omachi; Satoshi Takahashi; Ikuo Sakuma; Takahiro Otani; Jiro Watarai; Kazuo Ishikawa; Hiroyuki Kinouchi; Kazuo Mizoi
Journal:  AJNR Am J Neuroradiol       Date:  2005-09       Impact factor: 3.825

4.  Treatment and follow-up of 22 unruptured wide-necked intracranial aneurysms of the internal carotid artery with Onyx HD 500.

Authors:  Werner Weber; Ralf Siekmann; Bernhard Kis; Dietmar Kuehne
Journal:  AJNR Am J Neuroradiol       Date:  2005-09       Impact factor: 3.825

5.  Feasibility of using intravascular ultrasonography for assessment of giant cavernous aneurysm after endovascular treatment: a technical report.

Authors:  Shahram Majidi; Mikayel Grigoryan; Wondwossen G Tekle; Masaki Watanabe; Adnan I Qureshi
Journal:  J Vasc Interv Neurol       Date:  2012-06

6.  GDC Embolisation of Cavernous Internal Carotid Artery Aneurysms with Parent Artery Preservation.

Authors:  S J Kim; I S Choi
Journal:  Interv Neuroradiol       Date:  2001-05-15       Impact factor: 1.610

7.  Clinical and angiographic outcome of endovascular and conservative treatment for giant cavernous carotid artery aneurysms.

Authors:  Zhenhai Zhang; Xianli Lv; Zhongxue Wu; Youxiang Li; Xinjian Yang; Chuhan Jiang; Ruxiang Xu; Chunsen Shen
Journal:  Interv Neuroradiol       Date:  2014-02-10       Impact factor: 1.610

8.  Long term visual and neurological prognosis in patients with treated and untreated cavernous sinus aneurysms.

Authors:  N Goldenberg-Cohen; C Curry; N R Miller; R J Tamargo; K P J Murphy
Journal:  J Neurol Neurosurg Psychiatry       Date:  2004-06       Impact factor: 10.154

9.  Endovascular treatment of remnants of intracranial aneurysms following incomplete clipping.

Authors:  B Lubicz; X Leclerc; J Y Gauvrit; J P Lejeune; J P Pruvo
Journal:  Neuroradiology       Date:  2004-03-04       Impact factor: 2.804

10.  Giant aneurysms of the internal carotid artery: endovascular treatment and long-term follow-up.

Authors:  B Lubicz; J Y Gauvrit; X Leclerc; J P Lejeune; J P Pruvo
Journal:  Neuroradiology       Date:  2003-08-16       Impact factor: 2.804

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.